Paper Review Records
All Paper Review Records
17 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
A pediatric central nervous system tumor with BCOR internal tandem duplication confirmed after initially inconclusive targeted molecular testing: a case report
Iori Ozono; Sumihito Nobusawa; Vishwa Jeet Amatya; Koichi Ichimura; Junko Hirato; Yohei Inoue; Takako Yoshioka; Kai Yamasaki; Kohei Fukuoka; Masahiro Sekiguchi; Shuhei Karakawa; Maiko Shimomura; Asuka Fujii; Motohiro Kato; Fumiyuki Yamasaki; Yukio Takeshima; Nobutaka HorieShow moreShow less
1. Department of Neurosurgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima City, Japan; 2. Department of Human Pathology, Graduate School of Medicine, Gunma University, Maebashi, Japan; 3. Department of Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan; 4. Department of Pathology, Kyorin University School of Medicine, Mitaka City, Japan; 5. Department of Pathology, Public Tomioka General Hospital, Tomioka City, Japan; 6. Department of Neurological Surgery, Dentistry, and Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Okayama City, Japan; 7. Department of Pathology, National Center for Child Health and Development, Tokyo, Japan; 8. Department of Pediatric Hematology/Oncology, Osaka City General Hospital, Osaka, Japan; 9. Department of Hematology/Oncology, Saitama Children’s Medical Center, Saitama, Japan; 10. Division of Cancer Genomics, Children’s Cancer Center, National Center for Child Health and Development, Tokyo, Japan; 11. Department of Pediatrics, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan; 12. Department of Pediatrics, Juntendo University Faculty of Medicine, Tokyo, Japan; 13. Department of Pediatrics, The University of Tokyo, Tokyo, JapanShow moreShow less
A case of infant-type hemispheric glioma, ALK-altered, with a 23-year long-term follow-up
Ryota Taomoto; Mikiko Aoki; Takato Tajiri; Toshiyuki Enomoto; Yukie Higuma; Junji Shibahara; Koichi Ichimura; Kaishi Satomi; Hiroshi Abe; Makoto HamasakiShow moreShow less
1. Department of Neurosurgery, Fukuoka University of Medicine, Fukuoka, Japan; 2. Department of Pathology, Fukuoka University of Medicine, Fukuoka, Japan; 3. Department of Neurosurgery, Hakujuji Hospital, Fukuoka, Japan; 4. Department of Radiology, Hakujuji Hospital, Fukuoka, Japan; 5. Department of Pathology, Kyorin University, Faculty of Medicine, Tokyo, JapanShow moreShow less
CDKN2A deletion associated with poor prognosis in patients with TERT promoter wild-type, IDH wild-type glioblastoma
Shigeru Kamimura; Yuta Mitobe; Kazuki Nakamura; Takanobu Kabasawa; Mitsuru Futakuchi; Yonehiro Kanemura; Yukihiko SonodaShow moreShow less
1. Department of Neurosurgery, Faculty of Medicine, Yamagata University, Yamagata City, Japan; 2. Department of Pathological Diagnostics, Faculty of Medicine, Yamagata University, Yamagata City, Japan; 3. Department of Biomedical Research and Innovation, Institute for Clinical Research, National Hospital Organization, Osaka National Hospital, Osaka, JapanShow moreShow less
Germinoma in late adulthood with extensive dissemination: a case report and literature review
Rindai Saito; Yosuke Kitagawa; Hirokazu Takami; Kento Mitani; Takashi Aoka; Mariko Tanaka; Masashi Nomura; Nobuhito SaitoShow moreShow less
1. Department of Neurosurgery, Faculty of Medicine, The University of Tokyo, Tokyo, Japan; 2. Department of Neurosurgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan; 3. Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, JapanShow moreShow less
Dural CIC :: DUX4 sarcoma presenting with intracranial hemorrhage at both initial diagnosis and recurrence: a case report and literature review
Shu Kimura; Shota Yamashita; Masayuki Kanamori; Yoshinari Osada; Yoshiteru Shimoda; Tomohiro Nakano; Hidetaka Niizuma; Mika Watanabe; Hidenori EndoShow moreShow less
1. Department of Neurosurgery, Tohoku University Graduate School of Medicine, Sendai, Japan; 2. Department of Pediatrics, Tohoku University Graduate School of Medicine, Sendai, Japan; 3. Department of Pathology, Tohoku Kosai Hospital, Sendai, JapanShow moreShow less
Meningioma enlargement associated with luteinizing hormone-releasing hormone agonist therapy: two cases and supporting in vitro evidence
Toshiya Ichinose; Masashi Kinoshita; Maki Sakaguchi; Sho Tamai; Shingo Tanaka; Mitsutoshi NakadaShow moreShow less
1. Department of Neurosurgery, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan; 2. Department of Diagnostic Pathology, Nara Medical University, Nara, JapanShow moreShow less
FAQ
How long does Brain Tumor Pathology take to review a manuscript?
As of 2026-11-19, CrushSCI has 17 complete review records for Brain Tumor Pathology. The fastest paper went from submission to acceptance in 77 days (Comparative molecular profiles of distinct tumor components in recurrent tentorial meningioma after stereotactic radiosurgery: a case report implicating acquired aggressive alterations associated with WHO grade progression, received 2025-08-28, accepted 2025-11-13); the slowest took 290 days. The average is 154.9 days and the median is 154 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
